✦ LIBER ✦

High-dose cisplatin in patients with advanced malignancies

✍ Scribed by Martin S. Blumenreich; Thomas M. Woodcock; Mariesa Jones; Stephen P. Richman; Patrick S. Gentile; Thomas T. Kubota; Joseph C. Allegra

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 427 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850301)55:5<1118::aid-cncr2820550529>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I, II study of high-dose 5-fluor

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies

✍ Bach Ardalan; Kasi S. Sridhar; Pasquale Benedetto; Stephen Richman; Stuart Waldm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 2 views

High response rate with a lower dose of

High response rate with a lower dose of paclitaxel in combination with cisplatin in heavily pretreated patients with advanced breast carcinoma

✍ Abdel G. Maiche; Antti P. Jekunen; Jaana Kaleva-Kerola; Guillermo Blanco Sequeir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

## BACKGROUND. Paclitaxel has been found to be efficacious in the treatment of breast carcinoma either when administered alone or in combination with other anticancer agents. Synergistic interaction between paclitaxel and cisplatin has been demonstrated in vitro. ## METHODS. Thirty-two patients w

Effects of high dose raloxifene in selec

Effects of high dose raloxifene in selected patients with advanced breast carcinoma

✍ William Gradishar; Joan Glusman; Yili Lu; Charles Vogel; Fredric J. Cohen; Georg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

BACKGROUND. An earlier trial of raloxifene, conducted in women with metastatic breast carcinoma who initially had responded to tamoxifen and subsequently developed disease progression, suggested no antitumor activity for raloxifene in tamoxifen-refractory disease. However, preclinical studies and pr

High dose tamoxifen plus cisplatin and e

High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma

✍ Chih-Hsin Yang; Ann-Lii Cheng; Kun-Huei Yeh; Chong-Jen Yu; Jing-Fang Lin; Pan-Ch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## BACKGROUND. Tamoxifen sensitizes cancer cells to chemotherapeutic agents. High dose tamoxifen has been tested in the treatment of patients with melanoma and other cancers. The authors conducted a Phase II study of high dose tamoxifen plus cisplatin and etoposide for patients with advanced, inop

High dose methotrexate with and without

High dose methotrexate with and without BCG therapy in advanced head and neck malignancy

✍ Mary Buechler; Bijay Mukherji; Werner Chasin; Larry Nathanson 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

Serum interleukin-10 levels in patients

Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies

✍ Ferdinando De Vita; Michele Orditura; Gennaro Galizia; Ciro Romano; Stefania Inf 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## BACKGROUND. Interleukin-10 (IL-10) is a cytokine with immunosuppressive properties. In this study, the authors investigated the prognostic significance of IL-10 levels in the sera of 58 patients with advanced gastric or colorectal carcinoma. ## METHODS. IL-10 serum levels were measured befor